These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 25022024)

  • 21. Towards a hit for every target.
    Rees S; Gribbon P; Birmingham K; Janzen WP; Pairaudeau G
    Nat Rev Drug Discov; 2016 Jan; 15(1):1-2. PubMed ID: 26585534
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drugs for Neglected Diseases initiative model of drug development for neglected diseases: current status and future challenges.
    Ioset JR; Chang S
    Future Med Chem; 2011 Sep; 3(11):1361-71. PubMed ID: 21879842
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Accelerating Medicines Partnership: Alzheimer's Disease (AMP-AD) Knowledge Portal Aids Alzheimer's Drug Discovery through Open Data Sharing.
    Hodes RJ; Buckholtz N
    Expert Opin Ther Targets; 2016; 20(4):389-91. PubMed ID: 26853544
    [No Abstract]   [Full Text] [Related]  

  • 24. Global initiative launches to speed up the discovery of new drugs.
    Gulland A
    BMJ; 2011 Feb; 342():d1074. PubMed ID: 21325376
    [No Abstract]   [Full Text] [Related]  

  • 25. Ebola: public-private partnerships.
    Reperant LA; van de Burgwal LH; Claassen E; Osterhaus AD
    Science; 2014 Oct; 346(6208):433-4. PubMed ID: 25342793
    [No Abstract]   [Full Text] [Related]  

  • 26. How academic labs can approach the drug discovery process as a way to synergize with big pharma.
    Loregian A; Palù G
    Trends Microbiol; 2013 Jun; 21(6):261-4. PubMed ID: 23731493
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Importance of Collaboration between Industry, Academics, and Nonprofits in Tropical Disease Drug Discovery.
    Ferrins L; Pollastri MP
    ACS Infect Dis; 2018 Apr; 4(4):445-448. PubMed ID: 29134797
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Precision Medicine in Chronic Obstructive Pulmonary Disease.
    Hurst JR
    Am J Respir Crit Care Med; 2016 Mar; 193(6):593-4. PubMed ID: 26977962
    [No Abstract]   [Full Text] [Related]  

  • 29. Precarious connections: making therapeutic production happen for malaria and tuberculosis.
    Craddock S
    Soc Sci Med; 2015 Mar; 129():36-43. PubMed ID: 25142906
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The innovative medicines initiative: a case study for new ways of working in drug R&D.
    Laverty H; Goldman M
    Future Med Chem; 2014 Apr; 6(5):489-91. PubMed ID: 24649951
    [No Abstract]   [Full Text] [Related]  

  • 31. How informatics can potentiate precompetitive open-source collaboration to jump-start drug discovery and development.
    Perakslis ED; Van Dam J; Szalma S
    Clin Pharmacol Ther; 2010 May; 87(5):614-6. PubMed ID: 20376001
    [No Abstract]   [Full Text] [Related]  

  • 32. The influenza vaccine innovation system and lessons for PDPs.
    Huzair F
    Hum Vaccin Immunother; 2012 Mar; 8(3):407-10. PubMed ID: 22327495
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Challenges for pharmaceutical industry: new partnerships for sustainable human health.
    Hunter J
    Philos Trans A Math Phys Eng Sci; 2011 May; 369(1942):1817-25. PubMed ID: 21464073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acceleration of drug development: a collaboration of many stakeholders.
    Reynolds KS
    Clin Pharmacol Ther; 2013 Jun; 93(6):455-9. PubMed ID: 23689207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Towards a European strategy for medicines research (2014-2020): The EUFEPS position paper on Horizon 2020.
    Gaspar R; Aksu B; Cuine A; Danhof M; Takac MJ; Linden HH; Link A; Muchitsch EM; Wilson CG; Ohrngren P; Dencker L
    Eur J Pharm Sci; 2012 Dec; 47(5):979-87. PubMed ID: 23046836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Allocation of control rights and cooperation efficiency in public-private partnerships: theory and evidence from the Chinese pharmaceutical industry.
    Zhang Z; Jia M; Wan D
    Int J Health Care Finance Econ; 2009 Jun; 9(2):169-82. PubMed ID: 19360467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improving R&D productivity of pharmaceutical companies through public-private partnership: experiences from the Innovative Medicines Initiative.
    Laverty H; Gunn M; Goldman M
    Expert Rev Pharmacoecon Outcomes Res; 2012 Oct; 12(5):545-8. PubMed ID: 23136843
    [No Abstract]   [Full Text] [Related]  

  • 38. Open PHACTS: semantic interoperability for drug discovery.
    Williams AJ; Harland L; Groth P; Pettifer S; Chichester C; Willighagen EL; Evelo CT; Blomberg N; Ecker G; Goble C; Mons B
    Drug Discov Today; 2012 Nov; 17(21-22):1188-98. PubMed ID: 22683805
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Into the valley of death: research to innovation.
    Hudson J; Khazragui HF
    Drug Discov Today; 2013 Jul; 18(13-14):610-3. PubMed ID: 23402848
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Understanding and creating value from open source drug discovery for neglected tropical diseases.
    Allarakhia M; Ajuwon L
    Expert Opin Drug Discov; 2012 Aug; 7(8):643-57. PubMed ID: 22657529
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.